Bis-Pectin & Glucolyte

Trusted and proven diarrhoea treatments

Helps prevent dehydration Helps prevent dehydration and restore fluid loss due to diarrhoea, vomiting, and gastroenteritis in people of all ages.  Contains therapeutic levels of glucose and electrolytes.  Efficacious formula developed at Royal Children’s Hospital, Brisbane, Australia.  Pleasant tasting. Learn more about Gold Cross Glucolyte

Provides effective symptomatic relief Provides effective symptomatic relief of acute, non-severe diarrhoea and minor gastro-intestinal upsets in adults nd children (over 8 years of age).  Reduces frequency by slowing gut motility. Reduces feelings of urgency. Improves stool consistency. Relieves associated abdominal pain. Can be used in pregnancy (Category “A”) Pleasant spearmint flavour. Learn more about Bis-Pectin

Gold Cross Glucolyte

Helps prevent dehydration

When to use?

To prevent dehydration and restore fluid loss due to diarrhoea, vomiting, and gastroenteritis in people of all ages.

The mainstay for antidiarrhoeal treatment is to maintain hydration or to re-hydrate the patient, and to prevent subsequent dehydration. The dehydration which occurs is due to a net loss of sodium, chloride, potassium, water and bicarbonate. Rehydration formulations (such as Glucolyte), when used correctly, avoid this potential for electrolyte disturbance. 

Children can become dehydrated very quickly and if no fluids are given, there is an isotonic (same electrolyte concentration as human blood) depletion of body fluids leading to fatigue, light-headedness, collapse and even death.

Active ingredients Contents per Glucolyte sachet:  

Why use - key benefits

• Glucolyte is a proven performer and you can be confident of its efficacy.
• Contains therapeutic levels (World Health Organisation (W.H.O.) guidelines) of glucose and electrolytes
• Replaces electrolytes quickly and effectively
• Available in two sizes of ready-to-mix sachets – for 600ml and single serve 200ml
• Pleasant tasting.
• Can be given to very young infants, children and adults.
• Also recommended during pregnancy and lactation.

Dosage

• Mild dehydration: 600mL–1200mL per day
• Moderate dehydration: Very young infants: 200-300mL per day
  Infants to 1 year: 600mL per day
  Children 1 to 6 years: 1200mL-1800mL per day
  Children more than 6 years and adults: 2400mL-4000mL per day

Pack size

• Powder for reconstitution. 12 x 13.3g sachet (individual serve): Each sachet dissolved in 200mL (glass) of freshly boiled and cooled water.
  
• 40 x 40g sachet: Each sachet dissolved in 600mL (jug) of freshly boiled and cooled water.

Cautions/Warnings

• Consult your doctor if you have persistent fluid loss.  

Top of page

Bis-Pectin

Provides effective symptomatic relief in diarrhoea  

When to use?

• Acute, non-severe diarrhoea and minor gastro-intestinal upsets in adults and
  children (over 8 years of age).

Active ingredients

• Each 15mL contains Codeine Phosphate 8.1mg, Light Kaolin 1.9g, Dried Aluminium Hydroxide 375mg, Pectin 120mg)    

  * The Gastro Intestinal Therapeutic Guidelines describe Codeine Phosphate as an effective motility reducing drug and describes its recommended doses. Bis-Pectin lies within these recommendations.    

Why use - key benefits

• Bis-Pectin has over 40 years’ history of proven performance, efficacy and reliability.
• Reduces frequency by slowing gut motility
• Reduces feelings of urgency
• Improves stool consistency
• Relieves associated abdominal pain
• Can be used in pregnancy (Category “A”)
• Gluten free
• Economical with 13 doses per 200ml bottle
• Pleasant spearmint flavour

Dosage

• Adults and children more than 12 years: 15mL hourly for 3 doses, then at 3 hourly intervals.
• Children 8 to 11 years: 11mL every 4 hours.

Pack size: 200mL (Suspension)

Cautions/Warnings

• Not recommended for children below 8 years.
• Persistent diarrhoeal symptoms.  

Note: Category “A” in Pregnancy: “Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.” (Source: MIMS, Medicines in Pregnancy, An Australian categorisation of risk of drug use in pregnancy.)